You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 November 2026 - Canadian pharmaceutical company Apotex Health Corp (TSX:APTX) announced on Monday the US launch of Axitinib Tablets, 1 mg and 5 mg, the first generic version of Pfizer's INLYTA, a kinase inhibitor indicated for the treatment o...
17 November 2026 - Biotechnology company Rakuten Medical Inc announced on Monday that it has initiated a Phase 1 clinical trial of RM-0256 photoimmunotherapy in Japan.RM-0256, an anti-PD-L1 antibody-light-activatable dye conjugate, is the third drug ...
17 November 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) said on Tuesday that its Japanese partner Eisai Co Ltd (TYO:4523) has presented new five-year data from the Clarity AD study and its long-term extension, showing in...
17 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Monday that China's National Medical Products Administration (NMPA) has accepted its supplemental New Drug Application (sNDA) for ivonescimab in combination wit...
17 November 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Monday that Alexion, AstraZeneca Rare Disease's Klygefa (gefurulimab) has been approved in both the US and the European Union for adults with an...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe